Rui ZhangAssociate Director, LNP Formulation at Tessera Therapeutics, USASpeaker
Agenda Sessions
Panel: Challenges for Non-Viral Delivery of Gene Therapies: Translating a First in Class to the Clinic
, 11:35amView Session